AR020897A1 - VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE - Google Patents
VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTEInfo
- Publication number
- AR020897A1 AR020897A1 ARP990105247A ARP990105247A AR020897A1 AR 020897 A1 AR020897 A1 AR 020897A1 AR P990105247 A ARP990105247 A AR P990105247A AR P990105247 A ARP990105247 A AR P990105247A AR 020897 A1 AR020897 A1 AR 020897A1
- Authority
- AR
- Argentina
- Prior art keywords
- vector
- selectly
- replicating
- vectors
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4736—Retinoblastoma protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17268698A | 1998-10-15 | 1998-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020897A1 true AR020897A1 (es) | 2002-06-05 |
Family
ID=22628758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990105247A AR020897A1 (es) | 1998-10-15 | 1999-10-15 | VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1121441B1 (es) |
| JP (2) | JP4404490B2 (es) |
| KR (1) | KR100841815B1 (es) |
| CN (2) | CN101092636B (es) |
| AR (1) | AR020897A1 (es) |
| AT (1) | ATE348169T1 (es) |
| AU (1) | AU758354B2 (es) |
| BR (1) | BR9914527A (es) |
| CA (1) | CA2345900A1 (es) |
| CZ (1) | CZ301506B6 (es) |
| DE (1) | DE69934421T2 (es) |
| ES (1) | ES2279636T3 (es) |
| HK (1) | HK1040529B (es) |
| HU (1) | HU226602B1 (es) |
| IL (2) | IL142337A0 (es) |
| NO (1) | NO330666B1 (es) |
| NZ (2) | NZ528283A (es) |
| PL (1) | PL347898A1 (es) |
| SK (1) | SK4412001A3 (es) |
| TW (1) | TWI262948B (es) |
| WO (1) | WO2000022137A2 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU758354B2 (en) * | 1998-10-15 | 2003-03-20 | Canji, Inc. | Selectively replicating viral vectors |
| KR100492017B1 (ko) * | 2002-06-24 | 2005-05-30 | 학교법인고려중앙학원 | 인간 간엽줄기 세포를 이용한 항암치료방법 |
| GB0416487D0 (en) | 2004-07-23 | 2004-08-25 | Isis Innovation | Modified virus |
| ES2385251B1 (es) | 2009-05-06 | 2013-05-06 | Fundació Privada Institut D'investigació Biomèdica De Bellvitge | Adenovirus oncolíticos para el tratamiento del cáncer. |
| WO2013138650A1 (en) * | 2012-03-14 | 2013-09-19 | Salk Institute For Biological Studies | Adenoviral tumor diagnostics |
| WO2014153204A1 (en) | 2013-03-14 | 2014-09-25 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| EP2986306A4 (en) | 2013-04-18 | 2016-12-07 | Armo Biosciences Inc | METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING |
| AU2016312510A1 (en) | 2015-08-25 | 2018-03-08 | Armo Biosciences, Inc. | Methods of using Interleukin-10 for treating diseases and disorders |
| JP7054527B2 (ja) | 2016-02-23 | 2022-04-14 | ソーク インスティテュート フォー バイオロジカル スタディーズ | アデノウイルスの複製動態を測定するための高スループットアッセイ |
| JP7015551B2 (ja) | 2016-02-23 | 2022-02-15 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現 |
| WO2018111767A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| WO2019020992A1 (en) * | 2017-07-25 | 2019-01-31 | Oxford Genetics Limited | ADENOVIRAL VECTOR |
| US11485957B2 (en) * | 2017-10-10 | 2022-11-01 | Nantbio, Inc. | Modified EC7 cells having low toxicity to viral production payloads |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE178490T1 (de) * | 1993-02-16 | 1999-04-15 | Onyx Pharmaceuticals | Cytopathische viren zur therapie und prophylaxe der neoplasie |
| WO1998013508A1 (en) * | 1996-09-24 | 1998-04-02 | Dana-Farber Cancer Institute | Method of targeting malignant cells using an e2f responsive promoter |
| IL129922A0 (en) * | 1996-11-15 | 2000-02-29 | Canji Inc | Tissue specific expression of retinoblastoma protein |
| AU744725B2 (en) * | 1997-03-03 | 2002-02-28 | Cold Genesys, Inc. | Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| AU758354B2 (en) * | 1998-10-15 | 2003-03-20 | Canji, Inc. | Selectively replicating viral vectors |
-
1999
- 1999-10-14 AU AU63915/99A patent/AU758354B2/en not_active Ceased
- 1999-10-14 CA CA002345900A patent/CA2345900A1/en not_active Abandoned
- 1999-10-14 KR KR1020017004690A patent/KR100841815B1/ko not_active IP Right Cessation
- 1999-10-14 TW TW088117803A patent/TWI262948B/zh not_active IP Right Cessation
- 1999-10-14 EP EP99951481A patent/EP1121441B1/en not_active Expired - Lifetime
- 1999-10-14 CN CN2007101040311A patent/CN101092636B/zh not_active Expired - Fee Related
- 1999-10-14 NZ NZ528283A patent/NZ528283A/en unknown
- 1999-10-14 HU HU0104107A patent/HU226602B1/hu unknown
- 1999-10-14 ES ES99951481T patent/ES2279636T3/es not_active Expired - Lifetime
- 1999-10-14 CZ CZ20011129A patent/CZ301506B6/cs not_active IP Right Cessation
- 1999-10-14 SK SK441-2001A patent/SK4412001A3/sk unknown
- 1999-10-14 PL PL99347898A patent/PL347898A1/xx not_active Application Discontinuation
- 1999-10-14 JP JP2000576027A patent/JP4404490B2/ja not_active Expired - Fee Related
- 1999-10-14 IL IL14233799A patent/IL142337A0/xx unknown
- 1999-10-14 AT AT99951481T patent/ATE348169T1/de not_active IP Right Cessation
- 1999-10-14 DE DE69934421T patent/DE69934421T2/de not_active Expired - Lifetime
- 1999-10-14 WO PCT/US1999/021452 patent/WO2000022137A2/en active IP Right Grant
- 1999-10-14 BR BR9914527-8A patent/BR9914527A/pt not_active IP Right Cessation
- 1999-10-14 CN CNB998143618A patent/CN1325647C/zh not_active Expired - Fee Related
- 1999-10-14 NZ NZ510805A patent/NZ510805A/en not_active IP Right Cessation
- 1999-10-15 AR ARP990105247A patent/AR020897A1/es active IP Right Grant
-
2001
- 2001-04-01 IL IL142337A patent/IL142337A/en not_active IP Right Cessation
- 2001-04-10 NO NO20011843A patent/NO330666B1/no not_active IP Right Cessation
-
2002
- 2002-02-08 HK HK02101003.1A patent/HK1040529B/zh not_active IP Right Cessation
-
2009
- 2009-08-04 JP JP2009181782A patent/JP2009254385A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR020897A1 (es) | VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE | |
| HUP0004853A3 (en) | Hepatitis c inhibitor peptides, process for preparation thereof, pharmaceutical compositions comprising thereof, their use and their intermediates | |
| HUP0104548A3 (en) | Hepatitis c inhibitor peptides, process for their preparation, pharmaceutical compositions conprising thereof and their use | |
| SG113402A1 (en) | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | |
| HUP0104574A3 (en) | Analogues of glp-1, pharmaceutical compositions comprising thereof and their use | |
| CZ297999A3 (cs) | Arylsulfonamidy a jejich analogy, způsob jejich výroby, meziprodukty pro jejich výrobu, farmaceutické prostředky tyto látky obsahující a jejich použití | |
| EE200000380A (et) | 11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks | |
| HUP0004400A3 (en) | Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
| DK1066049T3 (da) | Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse | |
| BR9807814B1 (pt) | composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto. | |
| HUP0004040A3 (en) | Pleuromutilin derivatives as antimicrobials, process for their preparation, pharmaceutical compositions, comprising thereof and their use | |
| FR2811552B1 (fr) | Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide | |
| HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
| HUP0002404A3 (en) | Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use | |
| IL98845A0 (en) | Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them | |
| GB0029936D0 (en) | A pharmaceutical formulation suitable for the treatment of hepititis B, hepititis C and other viral infections of the liver and a process for its preparation | |
| GB2327190B (en) | Process for the preparation of depilatory compositions and their use | |
| HUP0202233A3 (en) | Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them | |
| IL113484A0 (en) | Viral proteins pharmaceutical compositions containing them their preparation and use | |
| NO951418D0 (no) | Peptidderivater, deres fremstilling og anvendelse som terapeutika | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
| CO5050337A1 (es) | Composiciones farmaceuticas que incluyen polipeptidos il-18 y preparacion de la misma | |
| EE04260B1 (et) | Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine | |
| HUP0302291A3 (en) | Sulfonamide derivatives, process for their preparation and their use for preparation of pharmaceutical compositions | |
| AR002978A1 (es) | Compuestos benzamidas, composiciones farmacéuticasque los contienen, metodos para preparar los mismos y el uso de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |